These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 38341127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
    Wang X, Han M, Wang S, Sun Y, Zhao W, Xue Z, Liang X, Huang B, Li G, Chen A, Li X, Wang J.
    Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
    Xie R, Chen X, Cheng L, Huang M, Zhou Q, Zhang J, Chen Y, Peng S, Chen Z, Dong W, Huang J, Lin T.
    Mol Ther; 2021 Jan 06; 29(1):291-307. PubMed ID: 32950106
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma.
    Hu Z, Dong L, Li S, Li Z, Qiao Y, Li Y, Ding J, Chen Z, Wu Y, Wang Z, Huang S, Gao Q, Zhao Y, He X.
    Hepatology; 2020 Aug 06; 72(2):548-568. PubMed ID: 31815296
    [Abstract] [Full Text] [Related]

  • 8. NONO and tumorigenesis: More than splicing.
    Feng P, Li L, Deng T, Liu Y, Ling N, Qiu S, Zhang L, Peng B, Xiong W, Cao L, Zhang L, Ye M.
    J Cell Mol Med; 2020 Apr 06; 24(8):4368-4376. PubMed ID: 32168434
    [Abstract] [Full Text] [Related]

  • 9. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B.
    J Exp Clin Cancer Res; 2020 Sep 29; 39(1):203. PubMed ID: 32993738
    [Abstract] [Full Text] [Related]

  • 10. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
    Snijders AP, Hautbergue GM, Bloom A, Williamson JC, Minshull TC, Phillips HL, Mihaylov SR, Gjerde DT, Hornby DP, Wilson SA, Hurd PJ, Dickman MJ.
    RNA; 2015 Mar 29; 21(3):347-59. PubMed ID: 25605962
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma.
    Xue Z, Yang B, Xu Q, Zhu X, Qin G.
    Biochem Biophys Res Commun; 2020 Feb 19; 522(4):952-959. PubMed ID: 31810606
    [Abstract] [Full Text] [Related]

  • 12. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
    Chen Y, Xu X, Ding K, Tang T, Cai F, Zhang H, Chen Z, Qi Y, Fu Z, Zhu G, Dou Z, Xu J, Chen G, Wu Q, Ji J, Zhang J.
    J Exp Clin Cancer Res; 2024 Feb 02; 43(1):39. PubMed ID: 38303029
    [Abstract] [Full Text] [Related]

  • 13. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
    Sun G, Zhou H, Chen K, Zeng J, Zhang Y, Yan L, Yao W, Hu J, Wang T, Xing J, Xiao K, Wu L, Ye Z, Xu H.
    J Exp Clin Cancer Res; 2020 Jun 19; 39(1):116. PubMed ID: 32560659
    [Abstract] [Full Text] [Related]

  • 14. circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression.
    Li H, Jiao W, Song J, Wang J, Chen G, Li D, Wang X, Bao B, Du X, Cheng Y, Yang C, Tong Q, Zheng L.
    J Exp Clin Cancer Res; 2023 Nov 23; 42(1):313. PubMed ID: 37993881
    [Abstract] [Full Text] [Related]

  • 15. The transcription-splicing protein NonO/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression.
    Yadav SP, Hao H, Yang HJ, Kautzmann MA, Brooks M, Nellissery J, Klocke B, Seifert M, Swaroop A.
    Hum Mol Genet; 2014 Apr 15; 23(8):2132-44. PubMed ID: 24301678
    [Abstract] [Full Text] [Related]

  • 16. Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTEN.
    Yang L, Chen Y, Liu N, Shi Q, Han X, Gan W, Li D.
    J Hematol Oncol; 2021 Mar 19; 14(1):46. PubMed ID: 33741027
    [Abstract] [Full Text] [Related]

  • 17. Alternative splicing-related factor YT521: an independent prognostic factor in endometrial cancer.
    Zhang B, zur Hausen A, Orlowska-Volk M, Jäger M, Bettendorf H, Stamm S, Hirschfeld M, Yiqin O, Tong X, Gitsch G, Stickeler E.
    Int J Gynecol Cancer; 2010 May 19; 20(4):492-9. PubMed ID: 20686370
    [Abstract] [Full Text] [Related]

  • 18. Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.
    Yang Y, Li H, Liu K, Zou L, Xiang S, Geng Y, Li X, Qiu S, Yang J, Cui X, Li L, Li Y, Li W, Yan S, Liu L, Wu X, Liu F, Wu W, Chen S, Liu Y.
    J Transl Med; 2024 Mar 22; 22(1):299. PubMed ID: 38519939
    [Abstract] [Full Text] [Related]

  • 19. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.
    Liu S, Li H, Zhu Y, Ma X, Shao Z, Yang Z, Cai C, Wu Z, Li M, Gong W, Wu X.
    Cancer Lett; 2022 Oct 28; 547():215862. PubMed ID: 35953000
    [Abstract] [Full Text] [Related]

  • 20. PTBP3 Mediates IL-18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer.
    Zhao C, Zhao JW, Zhang YH, Zhu YD, Yang ZY, Liu SL, Tang QY, Yang Y, Wang HK, Shu YJ, Dong P, Wu XS, Gong W.
    Adv Sci (Weinh); 2024 Oct 28; 11(38):e2406633. PubMed ID: 39116343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.